Apple Inc. (NASDAQ: AAPL) was started with an Outperform rating and a $630 price target by Macquarie.
Boeing Co. (NYSE: BA) is feeling the brunt of a large and surprising call on Friday — Goldman Sachs downgraded the aerospace and defense player to Neutral from Buy, and the price target was slashed to $134 from $155.
Exelon Corp. (NYSE: EXC) was raised to Outperform from Neutral and the price target was raised to $35 from $23 at Credit Suisse, but more important is that the firm added it to the U.S. Focus List.
Herbalife Ltd. (NYSE: HLF) was downgraded to Hold from Buy at Argus. The call is not one of valuation, but is due to the FTC investigation creating limited upside in the near-term, despite trading at only 8.6 times expected earnings and having a solid core business.
Symantec Corp. (NASDAQ: SYMC) fired its CEO and issued slight downward guidance, which is rather pathetic for a data security leader at a time when data security is so important. Shares were down more than 8% at $18.80 on last look, and downgrades galore have been seen: to Neutral from Outperform at Baird; to Market Perform from Outperform at Cowen and Co.; to Neutral from Buy at UBS; estimates and targets were lowered at Bank of America Merrill Lynch and many other firms as well.
Other Key Analyst Calls
Albany Molecular Research Inc. (NASDAQ: AMRI) was downgraded to Underperform from Neutral at Sterne Agee.
ConAgra Foods Inc. (NYSE: CAG) was downgraded to Neutral from Buy at Goldman Sachs, and the price target was cut to $31 from $33 in the call.
Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) was maintained as Buy but the price target went from $45 to $43 at Nomura. We just featured how the worst may be over here.
Insulet Corp. (NASDAQ: PODD) was started as Buy at Sterne Agee, and the price target was set at $61.00, versus a close of $50.12.
JDS Uniphase Corp. (NASDAQ: JDSU) was raised to Buy from Neutral and the price target was raised to $18 from $15 at MKM Partners.
SanDisk Corp. (NASDAQ: SNDK) was reiterated as Buy and the price target was raised to $92 from $80 at Argus, based on positive NAND trends.
Tandem Diabetes Care Inc. (NASDAQ: TNDM) was started as Neutral at Sterne Agee, and the price target was set at $26, versus a $26.03 closing price.
Thermo Fisher Scientific Inc. (NYSE: TMO) was reiterated as Buy and the price target was raised to $142 from $128 based on upside from its recent LIFE deal.
United Technologies Corp. (NYSE: UTX) was raised to Buy from Neutral at Goldman Sachs.
Walgreen Co. (NYSE: WAG) was downgraded to Sell from Hold at Cantor Fitzgerald, and the downside price target was put at $50, versus a closing price of $66.50.
Top Gaining Stocks
Top Losing Stocks